Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Regular analgesic use and risk of multiple myeloma
Kirsten B. Moysich
, Mathew R. Bonner
, Gregory P. Beehler
, James R. Marshall
, Ravi J. Menezes
, Julie A. Baker
, Joli R. Weiss
,
Asher Chanan-Khan
Hematology / Oncology / Cancer Center / Breast Clinic
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Regular analgesic use and risk of multiple myeloma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Multiple Myeloma
100%
Confidence Interval
100%
Adjusted Odds Ratio
100%
Analgesic Use
100%
Acetaminophen
60%
Significant Risk Factors
40%
Aspirin
40%
Analgesic
40%
Cancer Institute
20%
Etiology
20%
Solid Tumors
20%
Chemoprevention
20%
Risk Reduction
20%
Case-cohort Study
20%
Population-based Case-control Study
20%
Malignant Neoplasms
20%
Medical Services
20%
Increasing Risk
20%
Hospital-based Case-control Study
20%
Hospital-based Study
20%
Sampling Bias
20%
Aspirin Use
20%
High-risk Myeloma
20%
Logistic Regression Analysis
20%
Benign Neoplasm
20%
Benign or Malignant
20%
Unconditional Logistic Regression
20%
Primary Incident
20%
Crude Odds Ratio
20%
Limited Samples
20%
Regular Users
20%
Chemoprotective Effect
20%
Nursing and Health Professions
Multiple Myeloma
100%
Analgesic Agent
100%
Odds Ratio
83%
Confidence Interval
83%
Tylenol
50%
Malignant Neoplasm
16%
Cancer Center
16%
Cohort Analysis
16%
Chemoprophylaxis
16%
Sample Size
16%
Logistic Regression Analysis
16%
Case-Control Study
16%
Benign Neoplasm
16%
Solid Malignant Neoplasm
16%
Health Care
16%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Analgesic Agent
100%
Acetylsalicylic Acid
50%
Paracetamol
50%
Malignant Neoplasm
33%
Case-Control Study
33%
Solid Malignant Neoplasm
16%
Cohort Study
16%
Tablet
16%
Benign Neoplasm
16%
Buffalo
16%
Medicine and Dentistry
Multiple Myeloma
100%
Odds Ratio
83%
Acetylsalicylic Acid
50%
Paracetamol
50%
Malignant Neoplasm
33%
Case-Control Study
33%
Solid Malignant Neoplasm
16%
Chemoprophylaxis
16%
Cohort Analysis
16%
Benign Tumor
16%
Logistic Regression Analysis
16%
Neuroscience
Aspirin
100%